Uncover and solve leading questions in dermatological and associated inflammatory diseases using a systems medicine approach.

Our ambition

DREAM aims to become a global leader in research on chronic inflammatory skin diseases and their multi-organ involvement within the next decade.

By combining advanced clinical expertise with discovery-driven research, DREAM will:

• deepen understanding of disease mechanisms
• identify new therapeutic targets
• redefine treatment approaches for patients worldwide

A translational approach

At the heart of DREAM is a translational systems medicine approach—bringing together laboratory discoveries and clinical applications.

We use cutting-edge omics technologies (genomics, transcriptomics, proteomics) alongside top-level clinical expertise across specialities.

This powerful integration allows us to:

• uncover the molecular and cellular mechanisms behind complex diseases
• discover new targets for treatment
• design innovative strategies for personalised and precision medicine

Extensive clinical and demographic data strengthen this approach, while clinical departments equipped with specialised trial units ensure that findings can be rapidly tested and applied.

An international hub

DREAM is set to become an internationally attractive centre for both research and education, offering opportunities from bachelor’s level to postdoctoral training. By striving for excellence, DREAM researchers will publish in top-ranking international journals and shape the future of dermatology research.

Looking ahead

With its bold vision, DREAM is uniquely positioned to:

• transform the field of inflammatory skin diseases and related comorbidities
• lead the way in translational and integrative research
• serve as a global model for collaborative, high-impact science